Oxytocin
Also called Pitocin, Syntocinon
No single human route established in this referenceProduct label
Research reference
Product label
Oxytocin obstetric product
Indication-specific IV infusion or intramuscular administration under clinical supervision
An acute monitored obstetric episode, not a wellness cycle
Oxytocin injection product label ↗When results may show
- When change was measured
- Maternal status, uterine activity and fetal status require monitoring. Infusion rates are adjusted to clinical response.
- When to assess
- An acute monitored obstetric episode, not a wellness cycle
- Conditions and limitations
- Supervised obstetric care. An obstetric label does not establish nasal social/cognitive use or an under-the-skin peptide-pen protocol. No outpatient starter is selected.
- When to stop
- Use the exact product's clinical monitoring and stopping instructions. A supply interval is not a stop date; severe or persistent reactions need prompt clinical review.
Sources: Oxytocin injection product label
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Key properties
- Formula
- C43H66N12O12S2
- Mol. weight
- 1,007.2 Da
- CAS
- 50-56-6
- PubChem CID
- 439302
External references
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 0.97× single dose
- Time to steady state
- 1hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Oxytocin injection product labelAn obstetric label does not establish nasal social/cognitive use or an under-the-skin peptide-pen protocol. No outpatient starter is selected.